Connect your AI

GRAIL, Inc. GRAL Operating Cash Flow

Operating Cash Flow at other companies

AbbottABT

$1.32B-7.2%

Guardant HealthGH

-$65.62M-4.7%

Natera, Inc.NTRA

$40.17M-9.6%

Tempus AI, Inc.TEM

-$73.28M+30.6%

ImmunomeIMNM

-$58.64M-10.5%

Adaptive BiotechnologiesADPT

-$9.54M+66.5%

Other financials

Income statement

Revenue$40.8M+28.1%

Operating income-$135.8M+11.6%

Net income-$93.2M+12.3%

EPS (diluted)-$2.29+26.1%

Balance sheet

Cash & equivalents$76.3M-44.4%

Total debt$51.0M-20.7%

Total equity$2.5B+3.6%

Total assets$2.8B-1.5%

Cash flow

CapEx$503.0K+711%

Free cash flow-$87.5M+8.0%

Valuation

Market cap$2.62B+145%

Enterprise value$2.6B+164%

P/S16.8×+8.6×

Profitability

Operating margin-348.7%-153pp

Net margin-253.2%-115pp

FCF margin-187.2%-60.4pp

Returns & leverage

Return on equity-16.1%—

Debt / equity0×0.0×

Current ratio11.7×+2.0×

Where this comes from

Reported directly by GRAIL, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: GRAIL, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about GRAIL, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is GRAIL, Inc.'s operating cash flow?: GRAIL, Inc. (GRAL) reported operating cash flow of -$86.99M in Q1 2026.
How has GRAIL, Inc.'s operating cash flow changed year-over-year?: GRAIL, Inc.'s operating cash flow increased by 8.4% year-over-year, from -$95.01M to -$86.99M.
What is the long-term trend for GRAIL, Inc.'s operating cash flow?: Over 2 years (2022 to 2025), GRAIL, Inc.'s operating cash flow has grown at a -27.0% compound annual growth rate (CAGR), from -$561.31M to -$299.01M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.